1. Home
  2. EIM vs CTKB Comparison

EIM vs CTKB Comparison

Compare EIM & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Municipal Bond

EIM

Eaton Vance Municipal Bond

HOLD

Current Price

$9.92

Market Cap

499.9M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.54

Market Cap

582.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EIM
CTKB
Founded
N/A
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.9M
582.3M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
EIM
CTKB
Price
$9.92
$4.54
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
148.2K
500.9K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.67
52 Week Low
$9.33
$2.37
52 Week High
$10.54
$6.18

Technical Indicators

Market Signals
Indicator
EIM
CTKB
Relative Strength Index (RSI) 58.15 51.58
Support Level $9.86 $4.00
Resistance Level $10.02 $4.60
Average True Range (ATR) 0.10 0.17
MACD 0.03 0.01
Stochastic Oscillator 95.56 43.69

Price Performance

Historical Comparison
EIM
CTKB

About EIM Eaton Vance Municipal Bond

Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: